DOH Advisory Against the Administration of Additional (Booster) Doses of COVID-19 Vaccines

The advisory provides a directive against the administration of additional (booster) COVID-19 doses aside from what is recommended under the Emergency Use Authorization from the Food and Drug Administration (FDA). Vaccine recipients shall only receive the recommended dose series from one (1) COVID-19 vaccine brand (English).